 | • レポートコード：QAF27775 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の医療用アスパラギナーゼ市場について種類別（大腸菌、エルウィニアクリサンテミ、ペグ化）、用途別（急性リンパ芽球性白血病、急性骨髄性白血病、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・医療用アスパラギナーゼ市場の概要 ・世界の主要地域別医療用アスパラギナーゼ市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の医療用アスパラギナーゼ市場規模2016-2021：種類別（大腸菌、エルウィニアクリサンテミ、ペグ化） ・世界の医療用アスパラギナーゼ市場予測2012-2027：種類別（大腸菌、エルウィニアクリサンテミ、ペグ化） ・世界の医療用アスパラギナーゼ市場規模2016-2021：用途別（急性リンパ芽球性白血病、急性骨髄性白血病、その他） ・世界の医療用アスパラギナーゼ市場予測2012-2027：用途別（急性リンパ芽球性白血病、急性骨髄性白血病、その他） ・医療用アスパラギナーゼのアメリカ市場規模と予測2016-2021 ・医療用アスパラギナーゼのヨーロッパ市場規模と予測2016-2021 ・医療用アスパラギナーゼの中国市場規模と予測2016-2021 ・医療用アスパラギナーゼの日本市場規模と予測2016-2021 ・医療用アスパラギナーゼの東南アジア市場規模と予測2016-2021 ・医療用アスパラギナーゼのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Jazz Pharmaceuticals、Takeda、Medac GmbH、Kyowa Hakko Kirin、Qianhong Bio-pharma、Taj Pharmaceuticals、Mingxing Pharma、Exova、United Biotech） ・医療用アスパラギナーゼの製造コスト分析 ・販売チャネル、流通業者、顧客 ・医療用アスパラギナーゼの市場動向・機会・課題 ・調査の結論 |
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin’s lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization’s List of Essential Medicines, the most effective and safe medicines needed in a health system.
The classification of Medical Asparaginase includes Escherichia coli, Erwinia Chrysanthemi and Pegylated, and the sales proportion of Escherichia coli in 2017 is about 64.6%, and the proportion is decreasing trend from 2013 to 2018.
Medical Asparaginase is widely sales for Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia and Others. The most proportion of Medical Asparaginase is sales in Acute Lymphoblastic Leukemia, and the consumption proportion is about 90% in 2017.
North America is the largest consumption place, with a revenue market share nearly 53.5% in 2017. Following North America, Europe is the second largest consumption place with the revenue market share of 37.2%, China is also an important sales region for the Medical Asparaginase, In China, the price is lower than the developed countries.
Market competition is intense. Jazz Pharmaceuticals, Shire, Medac GmbH, Kyowa Hakko Kirin, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Market Analysis and Insights: Global Medical Asparaginase Market
The global Medical Asparaginase market was valued at US$ 413.3 in 2020 and will reach US$ 449.3 million by the end of 2027, growing at a CAGR of 1.4% during 2022-2027.
Global Medical Asparaginase Scope and Market Size
The global Medical Asparaginase market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Asparaginase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Escherichia coli
Erwinia Chrysanthemi
Pegylated
Segment by Application
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other
The Medical Asparaginase market is analysed and market size information is provided by regions (countries). Segment by Application, the Medical Asparaginase market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Jazz Pharmaceuticals
Takeda
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
Exova
United Biotech
1 Medical Asparaginase Market Overview
1.1 Medical Asparaginase Product Scope
1.2 Medical Asparaginase Segment by Type
1.2.1 Global Medical Asparaginase Sales by Type (2016 & 2021 & 2027)
1.2.2 Escherichia coli
1.2.3 Erwinia Chrysanthemi
1.2.4 Pegylated
1.3 Medical Asparaginase Segment by Application
1.3.1 Global Medical Asparaginase Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Acute Lymphoblastic Leukemia
1.3.3 Acute Myeloid Leukemia
1.3.4 Other
1.4 Medical Asparaginase Market Estimates and Forecasts (2016-2027)
1.4.1 Global Medical Asparaginase Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Medical Asparaginase Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Medical Asparaginase Price Trends (2016-2027)
2 Medical Asparaginase Estimates and Forecasts by Region
2.1 Global Medical Asparaginase Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Medical Asparaginase Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Medical Asparaginase Sales Market Share by Region (2016-2021)
2.2.2 Global Medical Asparaginase Revenue Market Share by Region (2016-2021)
2.3 Global Medical Asparaginase Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Medical Asparaginase Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Medical Asparaginase Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Medical Asparaginase Estimates and Projections (2016-2027)
2.4.2 Europe Medical Asparaginase Estimates and Projections (2016-2027)
2.4.3 China Medical Asparaginase Estimates and Projections (2016-2027)
2.4.4 Japan Medical Asparaginase Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Medical Asparaginase Estimates and Projections (2016-2027)
2.4.6 India Medical Asparaginase Estimates and Projections (2016-2027)
3 Global Medical Asparaginase Competition Landscape by Players
3.1 Global Top Medical Asparaginase Players by Sales (2016-2021)
3.2 Global Top Medical Asparaginase Players by Revenue (2016-2021)
3.3 Global Medical Asparaginase Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Asparaginase as of 2020)
3.4 Global Medical Asparaginase Average Price by Company (2016-2021)
3.5 Manufacturers Medical Asparaginase Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Medical Asparaginase Market Size by Type
4.1 Global Medical Asparaginase Historic Market Review by Type (2016-2021)
4.1.1 Global Medical Asparaginase Sales Market Share by Type (2016-2021)
4.1.2 Global Medical Asparaginase Revenue Market Share by Type (2016-2021)
4.1.3 Global Medical Asparaginase Price by Type (2016-2021)
4.2 Global Medical Asparaginase Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Medical Asparaginase Sales Forecast by Type (2022-2027)
4.2.2 Global Medical Asparaginase Revenue Forecast by Type (2022-2027)
4.2.3 Global Medical Asparaginase Price Forecast by Type (2022-2027)
5 Global Medical Asparaginase Market Size by Application
5.1 Global Medical Asparaginase Historic Market Review by Application (2016-2021)
5.1.1 Global Medical Asparaginase Sales Market Share by Application (2016-2021)
5.1.2 Global Medical Asparaginase Revenue Market Share by Application (2016-2021)
5.1.3 Global Medical Asparaginase Price by Application (2016-2021)
5.2 Global Medical Asparaginase Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Medical Asparaginase Sales Forecast by Application (2022-2027)
5.2.2 Global Medical Asparaginase Revenue Forecast by Application (2022-2027)
5.2.3 Global Medical Asparaginase Price Forecast by Application (2022-2027)
6 North America Medical Asparaginase Market Facts & Figures
6.1 North America Medical Asparaginase Sales by Company
6.1.1 North America Medical Asparaginase Sales by Company (2016-2021)
6.1.2 North America Medical Asparaginase Revenue by Company (2016-2021)
6.2 North America Medical Asparaginase Sales Breakdown by Type
6.2.1 North America Medical Asparaginase Sales Breakdown by Type (2016-2021)
6.2.2 North America Medical Asparaginase Sales Breakdown by Type (2022-2027)
6.3 North America Medical Asparaginase Sales Breakdown by Application
6.3.1 North America Medical Asparaginase Sales Breakdown by Application (2016-2021)
6.3.2 North America Medical Asparaginase Sales Breakdown by Application (2022-2027)
7 Europe Medical Asparaginase Market Facts & Figures
7.1 Europe Medical Asparaginase Sales by Company
7.1.1 Europe Medical Asparaginase Sales by Company (2016-2021)
7.1.2 Europe Medical Asparaginase Revenue by Company (2016-2021)
7.2 Europe Medical Asparaginase Sales Breakdown by Type
7.2.1 Europe Medical Asparaginase Sales Breakdown by Type (2016-2021)
7.2.2 Europe Medical Asparaginase Sales Breakdown by Type (2022-2027)
7.3 Europe Medical Asparaginase Sales Breakdown by Application
7.3.1 Europe 135 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 135 Sales Breakdown by Application (2022-2027)
8 China Medical Asparaginase Market Facts & Figures
8.1 China Medical Asparaginase Sales by Company
8.1.1 China Medical Asparaginase Sales by Company (2016-2021)
8.1.2 China Medical Asparaginase Revenue by Company (2016-2021)
8.2 China Medical Asparaginase Sales Breakdown by Type
8.2.1 China Medical Asparaginase Sales Breakdown by Type (2016-2021)
8.2.2 China Medical Asparaginase Sales Breakdown by Type (2022-2027)
8.3 China Medical Asparaginase Sales Breakdown by Application
8.3.1 China 248 Sales Breakdown by Application (2016-2021)
8.3.2 China 248 Sales Breakdown by Application (2022-2027)
9 Japan Medical Asparaginase Market Facts & Figures
9.1 Japan Medical Asparaginase Sales by Company
9.1.1 Japan Medical Asparaginase Sales by Company (2016-2021)
9.1.2 Japan Medical Asparaginase Revenue by Company (2016-2021)
9.2 Japan Medical Asparaginase Sales Breakdown by Type
9.2.1 Japan Medical Asparaginase Sales Breakdown by Type (2016-2021)
9.2.2 Japan Medical Asparaginase Sales Breakdown by Type (2022-2027)
9.3 Japan Medical Asparaginase Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Medical Asparaginase Market Facts & Figures
10.1 Southeast Asia Medical Asparaginase Sales by Company
10.1.1 Southeast Asia Medical Asparaginase Sales by Company (2016-2021)
10.1.2 Southeast Asia Medical Asparaginase Revenue by Company (2016-2021)
10.2 Southeast Asia Medical Asparaginase Sales Breakdown by Type
10.2.1 Southeast Asia Medical Asparaginase Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Medical Asparaginase Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Medical Asparaginase Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Medical Asparaginase Market Facts & Figures
11.1 India Medical Asparaginase Sales by Company
11.1.1 India Medical Asparaginase Sales by Company (2016-2021)
11.1.2 India Medical Asparaginase Revenue by Company (2016-2021)
11.2 India Medical Asparaginase Sales Breakdown by Type
11.2.1 India Medical Asparaginase Sales Breakdown by Type (2016-2021)
11.2.2 India Medical Asparaginase Sales Breakdown by Type (2022-2027)
11.3 India Medical Asparaginase Sales Breakdown by Application
11.3.1 India Medical Asparaginase Sales Breakdown by Application (2016-2021)
11.3.2 India Medical Asparaginase Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Medical Asparaginase Business
12.1 Jazz Pharmaceuticals
12.1.1 Jazz Pharmaceuticals Corporation Information
12.1.2 Jazz Pharmaceuticals Business Overview
12.1.3 Jazz Pharmaceuticals Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Jazz Pharmaceuticals Medical Asparaginase Products Offered
12.1.5 Jazz Pharmaceuticals Recent Development
12.2 Takeda
12.2.1 Takeda Corporation Information
12.2.2 Takeda Business Overview
12.2.3 Takeda Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Takeda Medical Asparaginase Products Offered
12.2.5 Takeda Recent Development
12.3 Medac GmbH
12.3.1 Medac GmbH Corporation Information
12.3.2 Medac GmbH Business Overview
12.3.3 Medac GmbH Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Medac GmbH Medical Asparaginase Products Offered
12.3.5 Medac GmbH Recent Development
12.4 Kyowa Hakko Kirin
12.4.1 Kyowa Hakko Kirin Corporation Information
12.4.2 Kyowa Hakko Kirin Business Overview
12.4.3 Kyowa Hakko Kirin Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kyowa Hakko Kirin Medical Asparaginase Products Offered
12.4.5 Kyowa Hakko Kirin Recent Development
12.5 Qianhong Bio-pharma
12.5.1 Qianhong Bio-pharma Corporation Information
12.5.2 Qianhong Bio-pharma Business Overview
12.5.3 Qianhong Bio-pharma Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Qianhong Bio-pharma Medical Asparaginase Products Offered
12.5.5 Qianhong Bio-pharma Recent Development
12.6 Taj Pharmaceuticals
12.6.1 Taj Pharmaceuticals Corporation Information
12.6.2 Taj Pharmaceuticals Business Overview
12.6.3 Taj Pharmaceuticals Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Taj Pharmaceuticals Medical Asparaginase Products Offered
12.6.5 Taj Pharmaceuticals Recent Development
12.7 Mingxing Pharma
12.7.1 Mingxing Pharma Corporation Information
12.7.2 Mingxing Pharma Business Overview
12.7.3 Mingxing Pharma Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mingxing Pharma Medical Asparaginase Products Offered
12.7.5 Mingxing Pharma Recent Development
12.8 Exova
12.8.1 Exova Corporation Information
12.8.2 Exova Business Overview
12.8.3 Exova Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Exova Medical Asparaginase Products Offered
12.8.5 Exova Recent Development
12.9 United Biotech
12.9.1 United Biotech Corporation Information
12.9.2 United Biotech Business Overview
12.9.3 United Biotech Medical Asparaginase Sales, Revenue and Gross Margin (2016-2021)
12.9.4 United Biotech Medical Asparaginase Products Offered
12.9.5 United Biotech Recent Development
13 Medical Asparaginase Manufacturing Cost Analysis
13.1 Medical Asparaginase Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Medical Asparaginase
13.4 Medical Asparaginase Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Medical Asparaginase Distributors List
14.3 Medical Asparaginase Customers
15 Market Dynamics
15.1 Medical Asparaginase Market Trends
15.2 Medical Asparaginase Drivers
15.3 Medical Asparaginase Market Challenges
15.4 Medical Asparaginase Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Medical Asparaginase Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Medical Asparaginase Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Medical Asparaginase Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Medical Asparaginase Sales (MT) by Region (2016-2021)
Table 5. Global Medical Asparaginase Sales Market Share by Region (2016-2021)
Table 6. Global Medical Asparaginase Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Medical Asparaginase Revenue Share by Region (2016-2021)
Table 8. Global Medical Asparaginase Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Medical Asparaginase Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Medical Asparaginase Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Medical Asparaginase Revenue Share Forecast by Region (2022-2027)
Table 12. Global Medical Asparaginase Sales (MT) of Key Companies (2016-2021)
Table 13. Global Medical Asparaginase Sales Share by Company (2016-2021)
Table 14. Global Medical Asparaginase Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Medical Asparaginase Revenue Share by Company (2016-2021)
Table 16. Global Medical Asparaginase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Asparaginase as of 2020)
Table 17. Global Medical Asparaginase Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Medical Asparaginase Manufacturing Sites and Area Served
Table 19. Manufacturers Medical Asparaginase Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Medical Asparaginase Sales (MT) by Type (2016-2021)
Table 22. Global Medical Asparaginase Sales Share by Type (2016-2021)
Table 23. Global Medical Asparaginase Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Medical Asparaginase Price (USD/Kg) by Type (2016-2021)
Table 25. Global Medical Asparaginase Sales Share by Type (2022-2027)
Table 26. Global Medical Asparaginase Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Medical Asparaginase Revenue Share by Type (2022-2027)
Table 28. Global Medical Asparaginase Price (USD/Kg) by Type (2022-2027)
Table 29. Global Medical Asparaginase Sales (MT) by Application (2016-2021)
Table 30. Global Medical Asparaginase Sales Share by Application (2016-2021)
Table 31. Global Medical Asparaginase Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Medical Asparaginase Price (USD/Kg) by Application (2016-2021)
Table 33. Global Medical Asparaginase Sales (MT) by Application (2022-2027)
Table 34. Global Medical Asparaginase Sales Share by Application (2022-2027)
Table 35. Global Medical Asparaginase Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Medical Asparaginase Revenue Share by Application (2022-2027)
Table 37. Global Medical Asparaginase Price (USD/Kg) by Application (2022-2027)
Table 38. North America Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 39. North America Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 40. North America Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 42. North America Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 43. North America Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 44. North America Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 45. North America Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 46. North America Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 47. North America Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 48. North America Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 49. North America Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 50. Europe Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 51. Europe Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 52. Europe Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 54. Europe Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 55. Europe Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 56. Europe Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 57. Europe Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 58. Europe Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 59. Europe Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 60. Europe Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 61. Europe Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 62. China Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 63. China Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 64. China Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 66. China Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 67. China Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 68. China Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 69. China Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 70. China Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 71. China Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 72. China Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 73. China Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 74. Japan Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 75. Japan Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 76. Japan Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 78. Japan Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 79. Japan Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 80. Japan Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 81. Japan Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 82. Japan Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 83. Japan Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 84. Japan Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 85. Japan Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 98. India Medical Asparaginase Sales (MT) by Company (2016-2021)
Table 99. India Medical Asparaginase Sales Market Share by Company (2016-2021)
Table 100. India Medical Asparaginase Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Medical Asparaginase Revenue Market Share by Company (2016-2021)
Table 102. India Medical Asparaginase Sales by Type (2016-2021) & (MT)
Table 103. India Medical Asparaginase Sales Market Share by Type (2016-2021)
Table 104. India Medical Asparaginase Sales by Type (2022-2027) & (MT)
Table 105. India Medical Asparaginase Sales Market Share by Type (2022-2027)
Table 106. India Medical Asparaginase Sales by Application (2016-2021) & (MT)
Table 107. India Medical Asparaginase Sales Market Share by Application (2016-2021)
Table 108. India Medical Asparaginase Sales by Application (2022-2027) & (MT)
Table 109. India Medical Asparaginase Sales Market Share by Application (2022-2027)
Table 110. Jazz Pharmaceuticals Corporation Information
Table 111. Jazz Pharmaceuticals Description and Business Overview
Table 112. Jazz Pharmaceuticals Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. Jazz Pharmaceuticals Medical Asparaginase Product
Table 114. Jazz Pharmaceuticals Recent Development
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Business Overview
Table 117. Takeda Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Takeda Medical Asparaginase Product
Table 119. Takeda Recent Development
Table 120. Medac GmbH Corporation Information
Table 121. Medac GmbH Description and Business Overview
Table 122. Medac GmbH Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Medac GmbH Medical Asparaginase Product
Table 124. Medac GmbH Recent Development
Table 125. Kyowa Hakko Kirin Corporation Information
Table 126. Kyowa Hakko Kirin Description and Business Overview
Table 127. Kyowa Hakko Kirin Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Kyowa Hakko Kirin Medical Asparaginase Product
Table 129. Kyowa Hakko Kirin Recent Development
Table 130. Qianhong Bio-pharma Corporation Information
Table 131. Qianhong Bio-pharma Description and Business Overview
Table 132. Qianhong Bio-pharma Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Qianhong Bio-pharma Medical Asparaginase Product
Table 134. Qianhong Bio-pharma Recent Development
Table 135. Taj Pharmaceuticals Corporation Information
Table 136. Taj Pharmaceuticals Description and Business Overview
Table 137. Taj Pharmaceuticals Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Taj Pharmaceuticals Medical Asparaginase Product
Table 139. Taj Pharmaceuticals Recent Development
Table 140. Mingxing Pharma Corporation Information
Table 141. Mingxing Pharma Description and Business Overview
Table 142. Mingxing Pharma Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Mingxing Pharma Medical Asparaginase Product
Table 144. Mingxing Pharma Recent Development
Table 145. Exova Corporation Information
Table 146. Exova Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Exova Description and Business Overview
Table 148. Exova Medical Asparaginase Product
Table 149. Exova Recent Development
Table 150. United Biotech Corporation Information
Table 151. United Biotech Medical Asparaginase Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. United Biotech Description and Business Overview
Table 153. United Biotech Medical Asparaginase Product
Table 154. United Biotech Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Medical Asparaginase Distributors List
Table 158. Medical Asparaginase Customers List
Table 159. Medical Asparaginase Market Trends
Table 160. Medical Asparaginase Market Drivers
Table 161. Medical Asparaginase Market Challenges
Table 162. Medical Asparaginase Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Asparaginase Product Picture
Figure 2. Global Medical Asparaginase Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Medical Asparaginase Sales Market Share by Application in 2021 & 2027
Figure 6. Acute Lymphoblastic Leukemia Examples
Figure 7. Acute Myeloid Leukemia Examples
Figure 8. Other Examples
Figure 9. Global Medical Asparaginase Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Medical Asparaginase Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Medical Asparaginase Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Medical Asparaginase Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 13. Global Medical Asparaginase Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Medical Asparaginase Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Medical Asparaginase Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Medical Asparaginase Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Medical Asparaginase Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Medical Asparaginase Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Medical Asparaginase Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Medical Asparaginase Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Medical Asparaginase Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Medical Asparaginase Players Market Share by Revenue in Medical Asparaginase: 2016 & 2020
Figure 28. Medical Asparaginase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Medical Asparaginase Revenue Share by Type (2016-2021)
Figure 30. Global Medical Asparaginase Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Medical Asparaginase Revenue Share by Application (2016-2021)
Figure 32. Global Medical Asparaginase Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Medical Asparaginase Sales Market Share by Type in 2020
Figure 34. North America Medical Asparaginase Sales Market Share by Application in 2020
Figure 35. Europe Medical Asparaginase Sales Market Share by Type in 2020
Figure 36. Europe Medical Asparaginase Sales Market Share by Application in 2020
Figure 37. China Medical Asparaginase Sales Market Share by Type in 2020
Figure 38. China Medical Asparaginase Sales Market Share by Application in 2020
Figure 39. Japan Medical Asparaginase Sales Market Share by Type in 2020
Figure 40. Japan Medical Asparaginase Sales Market Share by Application in 2020
Figure 41. Southeast Asia Medical Asparaginase Sales Market Share by Type in 2020
Figure 42. Southeast Asia Medical Asparaginase Sales Market Share by Application in 2020
Figure 43. India Medical Asparaginase Sales Market Share by Type in 2020
Figure 44. India Medical Asparaginase Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Medical Asparaginase
Figure 47. Manufacturing Process Analysis of Medical Asparaginase
Figure 48. Medical Asparaginase Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
医療用アスパラギナーゼのグローバル市場2021 Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical u…- アスパラギナーゼのグローバル市場2021 Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical u…
- L-アスパラギナーゼのグローバル市場調査 2019年 The global L-Asparaginase market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on L-Asparaginase volume and value at global level, regional level and company level. From a global perspective, this report re…
- 世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes. Market Analysis and Insights: Global T-cell Acute Lymphoblastic Leukemia Treatment Market The global T-cell Acute Lymphoblastic…
- 急性リンパ芽球性白血病薬のグローバル市場調査 2019年 The global Acute Lymphoblastic Leukemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Lymphoblastic Leukemia Drug volume and value at global level, regional level and company level. Fro…